Have a personal or library account? Click to login
Understanding MASLD: Steatosis, MASH, Fibrosis, and Metabolic Syndrome Cover

Understanding MASLD: Steatosis, MASH, Fibrosis, and Metabolic Syndrome

Open Access
|Nov 2025

Figures & Tables

jbsr-109-1-4132-g1.png
Figure 1

Examples of steatotic and fibrotic livers at US, non‑contrast CT, and MR‑PDFF.

Source: Figure 1 is from Pickhardt PJ, Lubner MG. Noninvasive quantitative CT for diffuse liver diseases: steatosis, iron overload, & fibrosis. RadioGraphics 2025;45(1):e240176 with permission (authors retain the right from RSNA for reuse of images).

jbsr-109-1-4132-g2.png
Figure 2

Progression of liver‑specific disease in metabolic‑dysfunction associated steatotic liver disease (MASLD).

Source: Figure 2 is from Pickhardt PJ, Lubner MG. Noninvasive quantitative CT for diffuse liver diseases: steatosis, iron overload, & fibrosis. RadioGraphics 2025;45(1):e240176 with permission (authors retain the right from RSNA for reuse of images).

DOI: https://doi.org/10.5334/jbsr.4132 | Journal eISSN: 2514-8281
Language: English
Submitted on: Oct 2, 2025
Accepted on: Oct 6, 2025
Published on: Nov 13, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Perry J. Pickhardt, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.